Researchers make blood poisoning breakthrough

Jun 04, 2010

(PhysOrg.com) -- The lives of millions of people struck down by blood poisoning - or sepsis - could be saved after a team of researchers, including an expert from the University of Glasgow, made a medical breakthrough in how the condition is treated.

Blood poisoning often develops into septic shock which is an acute and systemic inflammatory condition. It leads to multi-organ damage, cardiovascular dysfunction and often death. Sepsis has a worldwide incidence of more than 20 million cases a year, with mortality due to reaching up to 50 per cent even in industrialised countries.

The treatment options available for are limited. However, Alirio J Melendez, Professor of Immunopharmacology at the University of Glasgow, and a team of researchers have discovered what could be a powerful weapon in the battle against the condition.

Prof Melendez’s and his team found a new molecular pathway stimulated by a lipid enzyme known as sphingosine kinase1 (SphK1) which is activated during the inflammation. When this molecular pathway is blocked, however, it significantly reduces the risk of death from blood poisoning.

The results of the study, which are reported in the latest edition of the scientific journal Science, showed that SphK1 is highly elevated in from patients with sepsis and inhibition of the molecular pathway reduced the proinflammatory response triggered by bacterial products in the human cells.

Moreover, the study also showed the mortality rate of mice with experimental sepsis was reduced when treated with a SphK1 blocker. The SphK1-inhibitor treated mice developed lower systemic inflammation, were protected from multi-organ failure, and had a much more efficient bacterial clearance than untreated mice.

Professor Melendez said: “Inhibitors of SphK1 may become therapeutic agents against this major class of disease which claims the lives of millions of people across the world each year.

“The incidence of sepsis is on the increase and clinical treatments are still inadequate so a medical breakthrough of this kind is timely and will hopefully lead to a way to treat this killer condition.”

The team of researchers made the pioneering discovery of the inflammatory mechanism controlled by SphK1 in an earlier study which found the expression and activity of SphK1 is grossly elevated in several immune cells following inflammatory stimulation.

Molecules were then designed to counteract the elevation and it was discovered they restore the cells to a more normal and less pro-inflammatory state. The finding suggested there could be a new treatment for sepsis and possibly other inflammatory diseases.

In the latest study, cutting-edge research technologies were employed by a multinational team of experts in immune cell biology from the UK, Europe and Singapore, who were brought in to share their clinical and scientific experience.

The purpose of the study was to provide sound evidence to better understand how SphK1 may control and to test whether drugs that target the molecule can successfully treat experimental .

Explore further: Hearing quality restored with bionic ear technology used for gene therapy

Provided by University of Glasgow

3.9 /5 (10 votes)

Related Stories

Promoting recovery from effects of severe allergic reaction

Apr 19, 2010

One of the life-threatening consequences of anaphylaxis, a severe allergic reaction that affects the function of multiple organ systems, is the widening of blood vessels that leads to a dramatic drop in blood pressure. New ...

Septic shock: Nitric oxide beneficial after all

Dec 15, 2009

Scientists at VIB and Ghent University in Flanders, Belgium have found an unexpected ally for the treatment of septic shock, the major cause of death in intensive care units. By inducing the release of nitric oxide (NO) gas ...

Key to out-of-control immune response in lung injury found

Aug 16, 2007

Researchers at the University of Illinois at Chicago College of Medicine have discovered how a protein modulates the inflammatory response in sudden, life-threatening lung failure. The protein's previously unknown role is ...

Drexel Research in Cytokines Could Treat Sepsis

Oct 27, 2006

Researchers from Drexel University and the University of Brighton in the U.K. have achieved groundbreaking results, which may significantly improve the treatment of sepsis. Their article, entitled “Mesoporous Carbide-Derived ...

Recommended for you

LED exposure is not harmful to human dermal fibroblasts

21 hours ago

There was a time when no one thought about light bulbs—one blew, you screwed another one in. Nowadays, it's more complicated, as energy efficiency concerns have given rise to a slew of options, including ...

User comments : 0

More news stories

Sensors may keep hospitalized patients from falling

(Medical Xpress)—To keep hospitalized patients safer, University of Arizona researchers are working on new technology that involves a small, wearable sensor that measures a patient's activity, heart rate, ...

Fresh hope for preventing pneumonia in the elderly

There are calls for the frail and elderly not be be overlooked for vaccines against pneumonia this winter, with UNSW research challenging conventional wisdom on immunisation effectiveness in older patients.

Phase transiting to a new quantum universe

(Phys.org) —Recent insight and discovery of a new class of quantum transition opens the way for a whole new subfield of materials physics and quantum technologies.

Imaging turns a corner

(Phys.org) —Scientists have developed a new microscope which enables a dramatically improved view of biological cells.

NASA image: Volcanoes in Guatemala

This photo of volcanoes in Guatemala was taken from NASA's C-20A aircraft during a four-week Earth science radar imaging mission deployment over Central and South America. The conical volcano in the center ...